Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)

[1]  Laura H. Tang,et al.  The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater , 2014, The American journal of surgical pathology.

[2]  N. Schultz,et al.  Recurrent SMARCA4 mutations in small cell carcinoma of the ovary , 2014, Nature Genetics.

[3]  T. Keck,et al.  Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin , 2013, BMC Cancer.

[4]  C. Pilarsky,et al.  Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome , 2013, PloS one.

[5]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[6]  A. Krasinskas,et al.  Ampullary Region Carcinomas: Definition and Site Specific Classification With Delineation of Four Clinicopathologically and Prognostically Distinct Subsets in an Analysis of 249 Cases , 2012, The American journal of surgical pathology.

[7]  Keunchil Park,et al.  Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Hechtman,et al.  HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications. , 2012, Archives of pathology & laboratory medicine.

[9]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[10]  M. Ladanyi,et al.  Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma–Rationale for Comprehensive Mutation Profiling , 2011, Molecular Cancer Therapeutics.

[11]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[12]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[13]  D. Lobo,et al.  HER‐2/Neu overexpression is a rare event in peri‐ampullary cancer: assessment using the HercepTestTM , 2009, Histopathology.

[14]  A. Hartmann,et al.  Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater , 2008, Virchows Archiv.

[15]  N. Schaefer,et al.  Carcinoma of the Ampulla of Vater: Comparative Histologic/Immunohistochemical Classification and Follow-up , 2004, The American journal of surgical pathology.

[16]  T. Kamigaki,et al.  Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. , 2001, Hepato-gastroenterology.

[17]  M. Ladanyi,et al.  Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping. , 2011, The Journal of molecular diagnostics : JMD.

[18]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..